N-Carbamyl-L-glutamic Acid - CAS 1188-38-1
Carglumic acid is an orphan drug, marketed by Orphan Europe under the trade name Carbaglu. Carglumic acid is used for the treatment of hyperammonaemia in patients with N-acetylglutamate synthase deficiency. The initial daily dose ranges from 100 to 250 mg/kg, adjusted thereafter to maintain normal plasma levels of ammonia.
Catalog Number: R055604
CAS Number: 1188-38-1
PubChem Substance ID:355035953
Molecular Formula: C₆H₁₀N₂O₅
Molecular Weight:190.15
Purity: ≥95%
* For research use only. Not for human or veterinary use.
Synonym
Synonyms | Carbaglu; Carbamino-L-glutamic Acid; Carbamylglutamic Acid; Carglumic Acid; N-Carbamoyl-L-glutamic Acid; N-Carbamoyl-S-glutamic Acid; N-Carbamyl-L-glutamic Acid; OE 312; Ureidoglutaric Acid; N-(Aminocarbonyl)-L-glutamic Acid; |
---|
Property
Molecular Formula: | C₆H₁₀N₂O₅ |
---|---|
Molecular Weight | 190.15 |
Purity | ≥95% |
Storage | Desiccate at RT |